Mix & Match! Buy ANY 10 Biomaterial Products, Get 3 Free! Use code Q2BG10Learn More
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
CLINICAL CASE
1 – Baseline buccal view: immediate implant placement was performed 3 months prior to replacing tooth #8. 2 – Baseline occlusal view: soft-tissue deficiency on the buccal aspect. 3 – Placement of Geistlich Fibro-Gide® with minimal envelope flap and inserting a temporary crown. 4 – Stabilization of Geistlich Fibro-Gide® to the buccal mucosa using internal mattress sutures.5 – 2-week follow-up at suture removal.6 – 4 weeks post-surgery: uneventful wound healing and an increase in soft-tissue volume. 7 – Occlusal view 11 months post-surgery: there is a clear substantial increase in the soft-tissue thickness.8 – Buccal view 11 months post-surgery: a substantial increase in soft-tissue thickness is evident.9 – Buccal view 2 years post-surgery.